Beta Blockers and Orthostatic Hypotension
Mechanism and Risk
- Beta blockers can exacerbate orthostatic hypotension through interference with normal baroreceptor function, particularly in older adults with decreased baroreceptor sensitivity, according to the European Heart Journal 1
- Alpha-beta blockers (carvedilol, labetalol) pose an even higher risk due to their additional alpha-blocking effects that cause vasodilation, as reported by the American College of Cardiology and Hypertension journal 2, 3
Patient Risk Factors
- Orthostatic hypotension risk is significantly increased in elderly patients (≥75 years), as stated by the European Heart Journal 1, 4
- Patients with moderate to severe frailty are also at increased risk, according to the European Heart Journal 5
Monitoring and Prevention
- Before starting or intensifying beta-blocker therapy, orthostatic hypotension testing is recommended, involving having the patient lie or sit for 5 minutes, then measuring blood pressure at 1 and/or 3 minutes after standing, as suggested by the European Heart Journal 4, 5
Management Recommendations
- For patients with hypertension and orthostatic hypotension, non-pharmacological approaches should be first-line treatment, and if beta blockers are necessary, consider alternative antihypertensive classes when possible, as recommended by the European Heart Journal 4, 5
- Switching from beta blockers to alternative antihypertensive classes, such as angiotensin receptor blockers or calcium channel blockers, is generally preferred in patients with coexisting hypertension and orthostatic hypotension, and avoiding alpha blockers is advised, as reported by the American College of Cardiology and Hypertension journal 2, 3, 4, 5
- In elderly or frail patients requiring antihypertensive therapy, long-acting dihydropyridine calcium channel blockers or RAS inhibitors are preferred first-line agents, and beta blockers should be avoided unless there are compelling indications, according to the European Heart Journal 5, 6
Special Considerations
- Beta blockers may be particularly problematic in patients with neurally mediated syncope, where they can enhance bradycardia, as reported by the European Heart Journal 7, 8
- Abrupt cessation of beta blockers should be avoided as it can cause rebound hypertension, as warned by the American College of Cardiology and Hypertension journal 2, 3